Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 -808.8%
March 31, 2026 -402.9%
December 31, 2025 -373.5%
September 30, 2025 -503.7%
June 30, 2025 -739.7%
March 31, 2025 -730.3%
December 31, 2024 -470.7%
September 30, 2024 -435.9%
June 30, 2024 -454.8%
March 31, 2024 -465.4%
December 31, 2023 -306.9%
September 30, 2023 -332.8%
June 30, 2023 -307.9%
March 31, 2023 -343.5%
December 31, 2022 -472.2%
September 30, 2022 -316.5%
June 30, 2022 -302.8%
March 31, 2022 -378.8%
December 31, 2021 -296.9%
September 30, 2021 -380.1%
June 30, 2021 -337.9%
March 31, 2021 -322.4%
December 31, 2020 -2.44K%
September 30, 2020 -227.9%
June 30, 2020 -792.3%
Date Value
March 31, 2020 -191.3%
December 31, 2019 -252.4%
September 30, 2019 -220.4%
June 30, 2019 -162.9%
March 31, 2019 -772.8%
December 31, 2018 -269.2%
September 30, 2018 -261.5%
June 30, 2018 -62.51%
March 31, 2018 -237.2%
December 31, 2017 -179.7%
September 30, 2017 -290.5%
June 30, 2017 -358.4%
March 31, 2017 -449.7%
December 31, 2016 -704.3%
September 30, 2016 -425.4%
June 30, 2016 -360.4%
March 31, 2016 -400.0%
December 31, 2015 -553.1%
September 30, 2015 -576.1%
June 30, 2015 -566.1%
March 31, 2015 -1.09K%
December 31, 2014 -550.6%
September 30, 2014 -2.48K%
June 30, 2014 -3.92K%
March 31, 2014 -402.7%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Enovis Corp. -0.18%
Edwards Lifesciences Corp. 13.87%
Intuitive Surgical, Inc. 17.20%
Kewaunee Scientific Corp. 2.78%
STAAR Surgical Co. 8.62%